Olmesartan Medoxomil (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the Olmesartan Medoxomil drug offered from Glenmark Pharmaceuticals Inc., USA. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
| NON-PROPRIETARY NAME: | Olmesartan Medoxomil |
| SUBSTANCE NAME: | OLMESARTAN MEDOXOMIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-05-25 |
| END MARKETING DATE: | 0000-00-00 |
Olmesartan Medoxomil HUMAN PRESCRIPTION DRUG Details:
| Item Description | Olmesartan Medoxomil from Glenmark Pharmaceuticals Inc., USA |
| LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2017-05-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68462-436_8e0adf3d-7569-4909-bab1-5fed9578ad77 |
| PRODUCT NDC: | 68462-436 |
| APPLICATION NUMBER: | ANDA203281 |
Other OLMESARTAN MEDOXOMIL Pharmaceutical Manufacturers / Labelers:
